PHVS Pharvaris NV
Health Care, filed as PHARVARIS N V (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
Who owns this now
Largest portfolio weights among holders, up to 0.4% (Andreas Halvorsen, Viking Global Investors). Not free-float ownership.
Who owns PHVS
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Andreas Halvorsen, Viking Global Investors | Hold | 3,653,310 | $126M | History |
Insider trades
Open-market buys and sales by PHVS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $17.1M sold by 9 insiders outside a trading plan
- $15.9M sold by 7 insiders under 10b5-1 plans
-
Viviane Monges DirectorSale$396K 11,969 shares at $33.05 69% of stakeTraded Sep 23 Filed Sep 25
-
Johannes Gerardus Christiaan Petrus Schikan DirectorSale$29K 800 shares at $36.19 0.7% of stakeTraded Sep 22 Filed Sep 24
-
David W. Nassif CFOSale$219K 6,000 shares at $36.47 5% of stakeTraded Sep 21 Filed Sep 23
-
Peng Lu PresidentSale$3.5M 100,000 shares at $35.00 61% of stakeTraded Sep 17 Filed Sep 21
-
Johannes Gerardus Christiaan Petrus Schikan DirectorSale$7M 200,000 shares at $35.00 64% of stakeTraded Sep 17 Filed Sep 21
-
Elisabeth Bjork DirectorSale$2M 52,500 shares at $37.89 78% of stakeTraded Sep 17 Filed Sep 21
-
Robert Glassman DirectorPlanned sale$559K 14,493 shares at $38.56 58% of stakeTraded Sep 17 Filed Sep 21
-
Anne Lesage Chief Early DevelopmentSale$765K 20,000 shares at $38.27 21% of stakeTraded Sep 17 Filed Sep 21
-
Stefan Andreas Abele Chief Technical Ops OfficerSale$1.8M 46,400 shares at $38.17 54% of stakeTraded Sep 15 Filed Sep 17
-
Robert Glassman DirectorPlanned sale$332K 8,667 shares at $38.27 45% of stakeTraded Sep 15 Filed Sep 17
-
Wim Souverijns Chief Commercial OfficerPlanned sale$1M 26,090 shares at $39.23 40% of stakeTraded Sep 14–15 Filed Sep 16
-
Peng Lu PresidentPlanned sale$602K 15,000 shares at $40.13 19% of stakeTraded Sep 11 Filed Sep 15
-
Berndt Modig CEOPlanned sale$90K 2,291 shares at $39.40 1.8% of stakeTraded Sep 14 Filed Sep 15
-
Anne Lesage Chief Early DevelopmentPlanned sale$1.1M 30,000 shares at $38.30 35% of stakeTraded Sep 10 Filed Sep 14
-
Robert Glassman DirectorPlanned sale$300K 8,000 shares at $37.55 43% of stakeTraded Sep 9 Filed Sep 11
Also filed in the last 12 months, not counted as buying or selling: 41 option exercises, 16 share withholdings for taxes, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 7 shown.
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.